Abstract -----------------------------------Spectrin
Introduction --------------------------------
The red blood cell membrane skeleton is formed principally by α 2 β 2 -spectrin heterotetramers that crosslink short protofilaments of F-actin at the distal (tail) ends of spectrin with the aid of protein 4.1R, which binds to both proteins. Actin and protein 4.1R bind to calponin homology domains in the actin-binding domain (ABD) at the N-terminus of the spectrin β -chain. 1 The adjacent, Cterminal end of α -spectrin, called the EF-domain, contains an N-terminal pair of calmodulin-like, Ca 2+ -responsive EF hands, termed EF 12 , that bind Ca 2+ with affinities in the low millimolar range, 2 and a C-terminal pair of Ca 2+ -insensitive EF hands, EF 34 , similar to those in α -actinin 3 , which extend to the C-terminus of the α -spectrin protein. Because Ca 2+ is not bound at the micromolar concentrations that exist inside red cells, and because Ca 2+ has no apparent effect on the binding of erythrocyte spectrin to actin, the EF-domain is generally assumed to be inert and vestigial in red cells. However, the sph 1J /sph 1J mouse, which has severe hereditary spherocytosis and unstable red cell membranes, makes a mutant α -spectrin that lacks the last 13 amino acids of the EF-domain and the protein. 4 The mutant protein is overexpressed by several-fold but is poorly incorporated into the RBC membrane skeleton, showing that the domain has some important but undiscovered function.
To test this possibility we constructed a minispectrin heterodimer from the actin-binding domain, the EF-domain and four adjacent spectrin repeats in each chain. Like native spectrin, the minispectrin interacts weakly with F-actin alone in a pelleting assay, but interacts strongly in the presence of protein 4.1R. Formation of the minispectrin-actin-4.1R ternary complex is greatly attenuated when the 13 C-terminal amino acids of α -spectrin are deleted, as in the sph 1J mouse, confirming that the EF-domain plays a major and previously unappreciated role in promoting spectrin-actin binding.
For personal use only. on November 16, 2017 . by guest www.bloodjournal.org From
---------------------------------------

Materials and Methods
Buffers
PBS: 150 mM NaCl, 5 mM Na phosphate, 0.5 mM EGTA, pH 8.0. Binding buffer: 120 mM KCl, 10 mM Hepes, 0.5 mM EGTA, 0.5 mM DTT, pH 7.5.
Recombinant Spectrin Peptides
The spectrin GST fusion proteins were made by subcloning PCR amplicons into GST expression vectors (Amersham Biosciences). cDNA clones of human spectrin AI (SPTA1; GenBank M61877), using the corrected carboxyterminal sequence of Galluzi et al (GenBank AF060556), and human spectrin BI (SPTB, GenBank J05500) were used as templates. α18-21EF (70,918 Da, amino acids (aa) 1805-2418) and α18-21EFΔ13 (69,390 Da, aa 1805-2417) were subcloned into pGex-6P. β ABD1-4 (86,396, aa 1-743) was cloned into pGex2T. All constructs were sequenced to verify their sequence. The proteins were expressed in E. coli BL21. A small overnight culture grown at 37°C was diluted 1:20 and grown further at 30°C until the OD 600 was 0.5 to 0.7. Expression was induced with 1mM IPTG (isopropyl-β-D-thiogalactopyranoside) and the cultures were grown at 30°C for an additional two hours. The bacterial pellets were stored at -80°C. Proteins were isolated at 4ºC using the protocol of Harper et al, 5 with modifications. The pellet from a 500 ml culture was resuspended in 10 ml of 130 mM NaCl, 10 mM sodium phosphate, pH 7.4, 5 mM EDTA, 5 μ g/ml leupeptin, 5 μ g/ml pepstatin and 5 μ M diisopropylfluorophosphate (DFP) and sonicated 3 times for 30 sec on ice. One ml of packed glutathione (GSH) Sepharose beads (Amersham Biosciences) was added to the centrifuged (30 min, 180,000 g) supernatant and the suspension was tumbled at 4°C for 1 hr. The protein-bound GSH beads were washed four times in PBS, and, when desired, the recombinant proteins were cleaved from GST with PreScission protease (pGex-6P) according to the manufacturer's directions (Amersham Biosciences) or with thrombin (pGex-2T), 40 U/ml beads at 25°C for 4 hrs. Protease digestions were terminated with 5 μ M DFP. Uncleaved GST proteins were eluted from GSH beads with 10 mM GSH for 4 hrs at 4°C and dialyzed vs two changes of 2 L of binding buffer for 48 hrs. Prior to binding experiments, all proteins were dialyzed against binding buffer. Examples of the recombinant fusion proteins are shown in Figure 1A .
Circular Dichroism Measurements
Stock solutions of the recombinant proteins were diluted in 10 mM sodium phosphate buffer, pH 7.4, 0.5 mM EGTA to the following concentrations: α 18-21EF to 0.0500 mg/ml; α 18-21EF∆13 to 0.0323 mg/ml, and β ABD1-4 to 0.0387 mg/ml. The circular dichroism (CD) profiles of these samples were obtained from 260 nm to 195 nm in 3.0 ml cuvettes with a 1.0 cm path length in an AVIV Circular Dichroism Spectrophotometer, Model 62DS. Protein concentrations of the stock protein solutions were obtained from absorption at 280 nm using molar extinction coefficients estimated from the amino acid analysis of each peptide. The measured ellipticities (Δε) were corrected to molar ellipticities (Θ, in units of deg cm 2 /dmole) using calculated mean residue weights of 115.5, 115.5 and 116.3 for α 18-21EF, α 18-21EF∆13 and β ABD1-4, respectively. The spectra of the recombinant proteins are shown in Figure 1B and indicate the proteins are folded and predominantly alpha helical. 
Minispectrin heterodimers
Minispectrins were prepared as described by Begg et al. 6 Equimolar amounts of the minispectrin peptides were incubated for 1 hr on ice and chromatographed on a prepacked Sephacryl S-200 column (Amersham Biosciences, Cat #17-1166-01) at 10 ml/hr. Two ml fractions were collected. The elution profile was monitored by SDS-PAGE. Fractions with equimolar amounts of α -and β -spectrin peptides were pooled and used for binding.
Protein 4.1R
Human erythrocyte protein 4.1R was extracted with 2 M Tris from erythrocyte membranes depleted of band 6, spectrin and actin. The extraction procedure of Dotimas et al 7 was used with one unit of de-identified human blood. The 2 M Tris extract was dialyzed after extraction against three changes of 2 L of 5 mM Na phosphate, 0.5 mM EGTA, pH 7.4, centrifuged (30 min, 180,000 g), and loaded on a 4 ml Q-Sepharose column (Amersham Biosciences) equilibrated with the dialysis buffer. The column was washed with 60 ml of 50 mM NaCl in column buffer, and protein 4.1R was eluted with 50 ml of 220 mM NaCl in column buffer. After evaluation by SDS-PAGE, the 4.1R was dialyzed against binding buffer.
Rabbit Skeletal Muscle Actin
Rabbit muscle acetone powder was purchased from Pel-Frez. The actin was prepared by the method of Spudich and Watt, 8 with the difference that F-actin was extracted with 800 mM KCl to dissociate the troponin rather than 0.6 mM KCl. The actin concentration was determined using the extinction coefficient of 0.617 (1 mg/ml, 1 cm light path) at 290 nm.
SDS-PAGE and Protein Determinations
SDS gel electrophoresis was performed in 9% Laemmli gels. 9 The concentration of protein 4.1R was determined with the BIO-RAD dye-binding assay using bovine serum albumin as the reference standard. The concentrations for the recombinant proteins were determined using extinction coefficients calculated from the amino acid sequence with the DNASTAR program Lasergene.
Radioactive Labeling of Proteins
Proteins were labeled with [
125 I]-Bolton Hunter reagent, 10 according to the manufacturer's directions (Perkin Elmer, Cat # NEX-120).
GST Pull Down Binding Experiments
The protein components and buffers were mixed in a final volume of 300 μl in a 1.5 ml tube and tumbled at 25°C for 60 min. The binding buffer, described above, also contained 0.5 μg/ml leupeptin, pepstatin and Pefabloc, 1 mg/ml BSA, 2 mM MgCl 2 and 0.5 mM ATP. Forty μl of GSH beads, 1:1 in binding buffer, were added to each sample and tumbled an additional 60 min at 25°C. The total reaction was loaded in an Ultrafree-MC centrifugal filter device (Millipore, Cat.# UFC30GVNB), placed in a 10 x 73 mm polystyrene tube and centrifuged for 25 min. at 3100 rpm in a tabletop Beckman centrifuge. The pellets were washed once with 100 μl of binding buffer and the bound proteins were eluted from the beads with 100 μl of 1X SDS gel sample buffer. After centrifugation through the filter, the samples were either analyzed on SDS gels or, if labelled with 125 I, counted in a gamma counter.
F-Actin Pelleting Experiments
These experiments were identical to those in the previous paragraph except that the final reaction volume was 200 μl. After the one-hour binding reaction, two 70 μl aliquots at each point were centrifuged in Beckman cellulose propionate tubes in a Beckman 42.2Ti rotor at 20,000 RPM for 20 min to sediment the F-actin and associated proteins. Free [ 125 I]-protein was measured from a 20 μl aliquot taken from the supernatant meniscus of each tube and counted in a gamma counter. Two 20 μl aliquots of the reaction before centrifugation were counted and used as the value for [
125 I]-protein added.
Structure Prediction
We used the PSIPRED server (http://bioinf4.cs.ucl.ac.uk:3000/psipred/), the Advanced Protein Secondary Structure Prediction Server (http://imtech.res.in/raghava/apssp/), and the PROF Secondary Structure Prediction System (http://www.aber.ac.uk/~phiwww/prof/) to predict secondary structures from amino acid sequences. The program K2D2 was used to estimate the structure of peptides from far ultraviolet CD measurements (http://www.ogic.ca/projects/k2d2/).
Results
The minispectrin mimics full-length spectrin in interactions with actin and protein 4.1R
We constructed two minispectrins by combining a GST fusion protein containing the actin binding domain of β -spectrin and the first four spectrin repeats (GST-βABD1-4) with the last four repeats in the α -spectrin subunit followed by the EF-domain. One minispectrin had the normal EF-domain (α18-21EF). The other lacked the C-terminal 13 amino acids that are deleted in the sph 1J mutation (α18-21EFΔ13). Both peptides were stably expressed ( Figure 1A , lanes 3 & 4). Because spectrin repeats β 1 to β 4 and α 18 to α 21 contain the sites that nucleate the side-toside interaction of α -and β -spectrins to form the heterodimer, 6, 11 the two partial spectrin chains react spontaneously to form a minispectrin heterodimer ( Figure 1A , lanes 1 & 2). The peptides used to form the dimer contain some additional minor bands ( Figure 1A , lanes 3 to 5) but the minispectrin is pure after chromatography on Sephacryl G-200 ( Figure 1A, lanes 1 & 2) . The minispectrin peak is symmetrical and elutes at a mass of 209,000 daltons on a column calibrated with globular proteins. This is reasonably close to the expected mass of 184,000 daltons, especially if the minispectrin is elongated, as would be expected given the attached spectrin repeats. The data suggest the minispectrin is homogeneous and is a monomer.
As shown in Figure 2 , when the normal minispectrin is retrieved on GSH-beads after incubation with F-actin and protein 4.1R, large amounts of actin are bound (Figure 2 , lane 9, black arrow). Very little actin is bound in the absence of protein 4.1R (lane 5). There is also an increase in the amount of protein 4.1R bound (lane 9), which may reflect the increased binding affinity of 4.1R in the ternary complex or some binding of protein 4.1R to actin alone 12 . When the binding is measured the opposite way, by pelleting F-actin and assaying bound [
125 I]-labelled minispectrin, a similar result is observed ( Figure 3A ): robust binding in the presence of 4.1R and minimal binding without. Binding approaches a plateau at a level corresponding to utilization of all the 4.1R in the system. The addition of 20 μ M to 1 mM free Ca 2+ to the reaction had no effect on binding (data not shown). The binary and ternary complex binding curves are similar to the curves obtained by one of us (SEL) previously with intact, native erythrocyte spectrin, 13 showing that the minispectrin satisfactorily approximates the intact molecule.
Deletion of the C-terminal 13 amino acids of α -spectrin greatly decreases F-actin binding
The minispectrin containing the sph 1J mutation binds far less F-actin than the normal minispectrin in the presence of protein 4.1R (Figure 2 , lane 10, white arrow), and essentially no F-actin in its absence (compare lane 6 to the controls in lanes 7 & 8) . Similarly, in the pelleting assay with all three components, the mutant minispectrin binds to F-actin with much lower apparent affinity than the normal minispectrin does ( Figure 3B ). In this experiment, binding of the normal minispectrin to F-actin saturates at a value less than the concentration of protein 4.1R in the reaction, indicating that some of the protein 4.1R is inactive. In our experience, there is considerable variation in the ability of different preparations of purified, native 4.1R to promote spectrin-actin binding; however, the same preparation of 4.1R is used in both of the reactions in Figure 3B and in all other experiments where normal and mutant minispectrins are compared, so the relative ineffectiveness of the mutant minispectrin, compared to the normal, is unchanged. In addition, we performed multiple replicates of all experiments using different preparations of protein 4.1R to be sure the results were reproducible.
When the assay was reversed and the binding of [ 125 I]-labelled protein 4.1R to F-actin is measured at increasing minispectrin concentrations ( Figure 4A ) or the binding of [
125 I]-labelled minispectrin to F-actin is measured at increasing 4.1R concentrations (Figure 4B ), the mutant minispectrin is again much less effective. In both cases, the mutant protein exhibits a lower apparent affinity and a lower binding capacity at saturation. One trivial possibility to explain the results shown in Figures 3 and 4 is that the C-terminal deletion in the sph 1J mutation alters the assembly of the minispectrin heterodimer or inhibits its interaction with protein 4.1R. Neither is the case. In fact, the mutant α -spectrin peptide (α18-21EFΔ13) actually has about two to three times higher affinity for the β -spectrin peptide (GST-β ABD1-4) than does the normal α -spectrin peptide (α18-21EF)( Figure 5A ). The same pattern was observed in three independent experiments. GST-βABD1-4 bound the mutant peptide, 15 and their colleagues, using pelleting assays, but much less than the K d of 0.012 μ M that Podgórski and Elbaum obtained using fluorescence and microcalorimetry techniques. 16 Whichever number is correct, it appears that the α -spectrin EF-domain or the adjacent spectrin repeats enhance the binding of protein 4.1R to the actin binding domain by a factor of approximately 5 to 10.
The data in Figs 5A and 5B suggest that the C-terminal deletion of α -spectrin in the sph 1J mouse must primarily affect the binary interaction of the minispectrin with F-actin, and Figure   For 
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5C supports this deduction. Spectrin-actin binding is slight at the concentrations we were able to use, but clearly, the mutant minispectrin binds much less well to F-actin than the normal construct, and, in fact, hardly binds at all. The estimated K d of the normal minispectrin-actin interaction is roughly 1 μ M in Figure 5C Figure 6 ). The data emphasize the great effect that adding the EFdomain to the actin binding domain has on formation of the ternary complex.
------------------------------------------
Discussion
The N-terminal end of β -spectrin is well known to bind F-actin and protein 4.1R through its calponin homology domains, 1 but the neighboring EF-domain at the C-terminal end of α -spectrin has no known physiological function. The domain contains two proximal EF hands (EF 12 ) that resemble calmodulin structurally. They bind Ca 2+ ions at nonphysiologic concentrations (K d ~0.5 mM), 1, 18 transforming from a closed to open conformation, like calmodulin, in the process. 19 There are also two distal EF hands (EF 34 ) 2 that belong to the Ca 2+ -independent class, and are found in the same position in α -actinin, a related spectrin family member. 3 The sph 1J /sph 1J mouse, 4 which has severe hereditary spherocytosis and unstable red cell membranes, makes a mutant α -spectrin that lacks the last 13 amino acids of the EF-domain, which extends to the C-terminus of the protein. The deletion removes the final α -helix of EF 4 . This helix interacts intimately with the initial α -helix of EF 3 in the NMR structure of EF 34 from α -actinin, 3 so it is very likely that the deletion disrupts the overall structure of EF 34 in α -spectrin. This is consistent with the CD spectra, which show a significant difference between α 18-21EF and α 18-21EFΔ13 ( Figure 1B) . EF 34 folds independently of EF 12 , 2 so it is possible that the structure and function of EF 12 is not perturbed. This fits with our preliminary finding that Ca 2+ -binding, which is a function of EF 12 , 2 is not significantly altered in the recombinant EF domain containing the sph 1J mutation (data not shown). The mutant spectrin is overexpressed by severalfold but is poorly incorporated into the RBC membrane skeleton, 4 showing that the domain has some important function.
We have recently found one such function. The EF-domain binds protein 4.2, a 72-kDa peripheral membrane protein that associates with band 3, the erythrocyte anion channel. 20 Band 3, the red cell anion exchanger, also binds protein 4.2, but that association does not interfere with the interaction of protein 4.2 and α -spectrin. The data imply that a portion of band 3 is associated with the actin junctional complex and forms a second site for the attachment of the membrane skeleton to the lipid bilayer, complementing the spectrin-ankyrin-band 3 attachment at the other end of spectrin. Other recent reports show that band 3 interacts with adducin 21 and is part of a macromolecular complex that attaches to protein 4.1 in vivo 22 , support this idea.
However, loss of spectrin-4.2 binding would not be sufficient to explain the severe hemolysis that afflicts the sph 1J /sph 1J mouse, since complete loss of protein 4.2 in mice 23 or humans, 24 only produces mild hemolysis, spherocytosis and anemia. This led us to test the hypothesis that the EF-domain also contributes to the critical actin-binding function of spectrin, and the present studies clearly show this is true. The EF-domain greatly amplifies binding of a minispectrin to F-actin in the presence of protein 4.1R ( Figure 6 ) and this effect is muted by deletion of the last 13 amino acids in α -spectrin ( Figure 3B ), as in the sph 1J mutant. The mutation does not significantly alter assembly of the minispectrin heterodimer ( Figure 5A ) or binding of protein 4.1R to the minispectrin ( Figure 5B ), but it does impair the binary interaction between the minispectrin and F-actin ( Figure 5C ).
Interestingly, 25 years ago, Cohen and Langley showed that β -chains isolated from native erythrocyte spectrin wouldn't bind F-actin in the presence of protein 4.1R unless they were first recombined with α -spectrin chains. 25 Unfortunately, this observation was overlooked or forgotten, perhaps because it was not the primary message of the paper. Isolated α -spectrin chains did not bind to F-actin in the presence of 4.1R in their hands; nor did the isolated minispectrin α -chains (α18-21EF) in ours ( Figure 6 ). The maximal concentration of α 18-21EF we tested was only 1.5 μ M. It is possible a higher concentration might bind, but we think it is more likely that the EF-domain acts indirectly to regulate the actin binding domain rather than as an accessory actin binding partner.
One problem in trying to answer this question is that we do not have direct information about the structural arrangement of the proteins in the spectrin-actin-4.1R complex. But it is likely that spectrin will resemble other spectrin family members that bind F-actin. α -Actinin is a well studied example that features an N-terminal actin binding domain containing two tandem calponin homology (CH) domains, and a C-terminal EF-domain containing EF hands homologous to EF 12 and EF 34 of spectrin, separated by four spectrin repeats. Because α -actinins are a homodimer of antiparallel chains, each end of α -actinin contains neighboring calponin homology domains and EF-domains. The arrangement of these is known from cryoelectron microscopy combined with homology modeling, using crystal or NMR structures of isolated domains. 26, 27 Additional information is available from structures of the actin binding domains of other spectrin family members, such as fimbrin, 28 utrophin, 29 dystrophin 30 and plectin. 31 Figure 7 is a model for spectrin based on the structure of skeletal muscle α -actinin, 26 which contains Ca 2+ -dependent and Ca 2+ -independent EF hands like spectrin. 3 In the model, the two CH domains are in the "closed" conformation, where the CH domains are in close contact ( Figure  7B ). The CH domains can also adopt a more splayed-out "open" arrangement. 27 It isn't known which arrangement exists in spectrin, but in either case, the EF-domain remains in contact with the CH domains and on the side away from actin ( Figure 7B) . Thus, the model supports the concept that the EF hands exert their influence on actin binding through the CH domains and do not bind directly to actin.
The way the EF hands do this is not known. One possibility, proposed by Tang et al, 26 is that ligands cause the EF domains to bind the short linker connecting the CH domains, forcing them apart and altering actin binding. A second possibility is that the EF hands, specifically EF 34 , bind to the long linker that connects CH2 to the first spectrin repeat (R1) in beta spectrin, possibly altering the orientation of the two CH domains or their rearrangement upon binding actin. In muscle α -actinin, EF 34 binds some of the α -helical Z-repeats of titin, which lie in the groove between EF3 and EF4. 3 The CH2-R1 linker in α -actinin, which is predicted to be an α -helix, is similar to the Z-repeats, and acts like an internal pseudoligand. It also binds to EF 34 , blocking the interaction with the titin Z-repeat. 32 This autoinhibition is relieved in α -actinin by phosphatidylinositol-4,5-bisphosphate (PI-4,5-P 2 ), whose head group binds to CH2 and whose fatty acid tails may bind to the CH2-R1 linker. 33 PI-4,5-P 2 activates F-actin binding by α -actinin and it also greatly amplifies the binding of protein 4.1R to the CH2 domain of β -spectrin. 1 We suspect this second mechanism also operates in spectrin. As noted earlier, the C-terminal EF hands in alpha spectrin (EF 34 ) are homologous to EF 34 in muscle α -actinin, 3, 18 suggesting that they may also bind an α -helical ligand. And, as noted, we find that the EF-domain binds protein 4.2. 20 The 22-amino acid segment in protein 4.2 that binds spectrin (aa 470-492) 34 lies on the surface of protein 4.2 35 and is likely to be helical according to the structure predicting algorithms indicated in the Methods. As shown in Figure 7C , it is similar to the CH2-R1 linker peptide, also predicted to be α -helical, along two faces of the helix. Both peptides are highly conserved in mammals. The titin Z-repeat α -helix lies in the grove of the α -actinin EF 34 hands like a hot dog in a bun, 3 contacting the bound helix on two sides, so we would expect two conserved surfaces on other α -helical ligands if they bind the same way. This suggests that EF 34 may bind to both the CH2-R1 linker and to the spectrin binding site in protein 4.2, and, as in α -actinin, the competing interactions may constitute a regulatory switch, perhaps controlled by PI-4,5-P 2, that alters the binding of actin or 4.1R to the CH2 domain. Because protein 4.1R also binds calmodulin at Ca 2+ -sensitive and Ca 2+ -insensitive sites, 36 and the EF-domain resembles calmodulin structurally and itself binds calmodulin in the presence of Ca 2+ , a network of regulatory effects can be imagined.
We want to emphasize that we have no direct evidence supporting this hypothesis. Other hypotheses are easily imagined, including the possibility that the EF domain works by modifying the flexibility or structure of the actin binding domain when the two are in contact in a minispectrin. Fortunately, all these speculations are testable.
Recently, two more missense mutations, sph 3J and sph
4J
, have been identified in the EF domain or nearby spectrin repeats that produce a phenotype in mice similar to the sph 1J mutation studied here. 37 Similar mutations have not yet been described in humans with hereditary hemolytic anemias, but relatively few mutations have been identified in spectrin in hereditary spherocytosis (HS), especially in alpha spectrin, so it is possible that such mutations exist but have not yet been found. We hope the present paper will encourage investigators to look for Cterminal α -spectrin mutations in patients with HS, especially severe HS.
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